MedTrace Logo

A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia

NCT01880294 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 461

Last updated 2024-10-28

No results posted yet for this study

Summary

The purpose of the study is to evaluate the differences or similarities in the results obtained with two different scoring systems for chronic constipation in Asian participants consulting in gastroenterology clinics (the Asian Neurogastro-enterology and Motility Association (ANMA) chronic constipation (CC) diagnostic tool (diagnosis questionnaire) and the ROME III diagnosis criteria (western gold standard).

Conditions

Interventions

DRUG

No intervention

Asian participants diagnosed with chronic constipation using ANMA diagnostic questionnaire will be observed.

Sponsors & Collaborators

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC Clinical Trial · Janssen Research & Development, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-18
Primary Completion
2013-12-14
Completion
2013-12-14

Countries

  • China
  • Malaysia
  • Philippines
  • Singapore
  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01880294 on ClinicalTrials.gov